Bloomberg BusinessweekBloomberg Businessweek

Bloomberg Markets: Adviser Backs Dumping Mylan Board

View descriptionShare

Bloomberg Markets with Carol Massar and Cory Johnson. GUEST: Cynthia Koons Healthcare Reporter Bloomberg News Discussing Mylan NV facing an increasing backlash over its handling of the EpiPen pricing controversy, as a top proxy adviser urged shareholders to oust the drugmaker’s board.

 
  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

Bloomberg Businessweek

Listen for reporting from the magazine that helps global leaders stay ahead. Hosts Carol Massar an 
Social links
Follow podcast
Recent clips
Browse 5,190 clip(s)